You are a key healthcare player, who develops and/or markets medicines, vaccines, medical devices or in vitro diagnostics.
You are looking for a provider able to  optimize the value of your products to health authorities, in order to maximize their reimbursement.

stève consultants is a consulting expert in Market Access and HEOR. Our qualified consultants, our network and our human approach focusing on deliverables quality and timelines compliance makes stève consultants an key player in France since 2006.

10 years
of experience
loyal customers

Stève Bénard – Executive Director of stève consultants

Josselin Boussel, Head of Market access
of stève consultants since 2010

Market access

For more than 10 years, stève consultants has been specialized in:

  • strategic consulting for pricing & reimbursement,
  • development of arguments in clinic, public health interest, therapeutic value (SMR: service medical rendu and ASMR: amélioration du service medical rendu) and target population,
  • writing of listing and relisting dossier attending for health authorities (transparency dossier, CNEDiMTS and economic).

Our touch: Working closely with you through evaluation by the French National Authority for Health (HAS) as well as through negotiations with the French Economic Committee of Healthcare Products (CEPS).

Health-economic modeling

Our dedicated consultants conceive and develop:

  • simulation tools to serve the medico-marketing strategy,

  • health economic evaluation attending for health authorities (efficiency evaluation by the French Economic Committee of Evaluation in Public Health (CEESP), pricing negotiations with the CEPS…).

Design / Adaptation

  • cost-effectiveness model

  • cost-utility model

  • budget impact mode

Data collection

  • epidemiologic and clinic

  • healthcare consumption

  • unit costs


  • main analysis

  • uncertainty analysis

  • technical report

Our touch: Source of strategical and technical proposals alongside the project.

Aurélie Schmidt, Head of HEOR
of stève consultants since 2006

Charlotte Cancalon, Health-economist statistician
of stève consultants since 2009

Observational database studies

stève consultants realizes your observational studies from database notably claim database (PMSI, EGB, SNIIR-AM):

  • post-inscription studies demanded by health authorities,

  • ad-hoc pharmacocoepidemiological, epidemiologic or medico-economic study to sustain your Market Access strategy


schema 1 observational

use studies

schema 2 observational


schema 3 observational


schema 4 observational

Our touch: Support of a dedicated scientific steering committee / possible cross with clinical registry or physician’s panel.